Avadel
Clinical trials sponsored by Avadel, explained in plain language.
-
New Once-Nightly pill may simplify narcolepsy treatment
Symptom relief CompletedThis study tested a new once-nightly medication (FT218) for people with narcolepsy who experience excessive daytime sleepiness and sudden muscle weakness (cataplexy). The goal was to see if it is safe and tolerable over the long term, and whether people currently taking a twice-n…
Phase: PHASE3 • Sponsor: Avadel • Aim: Symptom relief
Last updated May 26, 2026 05:06 UTC
-
New narcolepsy drug LUMRYZ studied in Real-World setting
Symptom relief CompletedThis study looked at how LUMRYZ, a medicine for narcolepsy, works when used in regular medical practice. 71 adults with narcolepsy filled out questionnaires about their symptoms, treatment experience, and quality of life over 4 months. The main goal was to see if daytime sleepine…
Sponsor: Avadel • Aim: Symptom relief
Last updated May 26, 2026 04:35 UTC
-
New nighttime pill aims to ease daytime sleepiness in rare disorder
Symptom relief CompletedThis study tested a once-nightly medication called FT218 in 157 adults with idiopathic hypersomnia, a condition causing excessive daytime sleepiness despite long sleep. Participants took the drug or a placebo to see if it improved alertness and reduced symptoms over about 18 week…
Phase: PHASE3 • Sponsor: Avadel • Aim: Symptom relief
Last updated May 19, 2026 11:59 UTC